HOME >> MEDICINE >> NEWS
Brain's efforts to save itself during Alzheimer's may backfire

The creation of a new transgenic mouse that makes a mysterious brain chemical may lead to better understanding of why people with Alzheimers disease lose their memory.

The neurotransmitter galanin appears to play a role in the disease, and scientists are now trying to figure out how and why. Galanin is normally neuro-protective, following brain injury. One possibility is that the brain overproduces galanin during the early stages of Alzheimers in an effort to rescue the afflicted brain but, over time, the brains own attempted cure makes a bad situation worse.

"This could be a sad irony. The body may be detecting the underlying pathology of Alzheimer's and tries to rescue deteriorating brain cells with increased expression of galanin. Very early on in the disease, galanin might even be having beneficial effects," said Dr. Robert Steiner, a professor in the departments of Obstetrics and Gynecology, and Physiology and Biophysics, at the University of Washington School of Medicine. "As the brain attempts to rescue itself with galanin and the disease progresses, the overexpression of galanin may become its own problem. This excess of galanin may contribute to the cognitive decline that Alzheimer's patients and their families so dread. "

The findings of Steiner and colleagues are published in the March 20 issue of Proceedings of the National Academy of Sciences. Co-authors include Dr. Jacqueline N. Crawley, chief of the Section on Behavioral Neuropharmacology, the National Institute of Mental Health; Dr. Elliott J. Mufson, professor in the Department of Neurological Sciences at Rush Presbyterian-St. Lukes Medical Center in Chicago; and Dr. John Hohmann, who was then a doctoral student in the neurobiology and behavior program at the University of Washington.

If galanin is playing a role in the disease, then what we know as Alzheimers could be the result of many parallel events that themselves create complications. Crawley said that galanin will need to b
'"/>

Contact: Walter Neary
wneary@u.washington.edu
206-685-3841
University of Washington
18-Mar-2001


Page: 1 2 3 4

Related medicine news :

1. Brains nicotine receptors also target for anti-depressants
2. Brains immune system triggered in autism
3. Brains daydream network offers detection for Alzheimers diagnosis
4. Novel Imaging Agent Developed By Penn Researchers Provides Insight Into Brains Message Delivery System
5. PITT Researchers Demonstrate Human Brains Natural Mechanism For Guarding Against Errors
6. 3D Ultrasound Gives Better View Of Brains Arteries
7. Computational tool predicts how drugs work in cells, advancing efforts to design better medicines
8. New European cancer figures for 2004 major efforts needed against the big four killers
9. Campus can be effective site for anti-smoking efforts
10. HIV/AIDS conspiracy theories may hamper efforts to halt the disease
11. Exposed: Tobacco industrys efforts to cast doubt

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Brain efforts save itself during Alzheimer may backfire

(Date:10/30/2014)... By Dennis Thompson ... -- Drinking lots of milk could be bad for your ... that the calcium in milk can help strengthen bones and ... health officials to recommend milk as part of a healthy ... amounts of milk did not protect men or women from ...
(Date:10/30/2014)... 29, 2014 (HealthDay News) -- Eating a low-carb, high-fat ... treat, according to new research. A review ... Atkins diet, that focuses on foods like bacon, eggs, ... reduce seizures in adults whose condition doesn,t improve with ... percent of people with epilepsy whose seizures are not ...
(Date:10/30/2014)... new vaccine that could help prevent some cases of ... Food and Drug Administration on Wednesday. Trumenba is ... and 25 from invasive meningococcal disease caused by ... can infect the bloodstream (sepsis) and the lining that ... leading cause of bacterial meningitis, and infection can occur ...
(Date:10/30/2014)... standard of care for children facing acute myeloid leukemia ... in the latest edition of the New England ... John Wagner, Jr., M.D., director of the Pediatric Blood ... and a researcher in the Masonic Cancer Center, University ... and myelodysplastic syndrome who received transplants of either one ...
(Date:10/29/2014)... 2014 – Many of the women at first acted surprised. ... to researchers why they had not used the study products ... prevention trial that, as a likely consequence, did not find ... effective. , The women were among 127 former VOICE ... D, agreed to take part in in-depth interviews and/or focus ...
Breaking Medicine News(10 mins):Health News:Is Milk Your Friend or Foe? 2Health News:Is Milk Your Friend or Foe? 3Health News:High-Fat, Low-Carb Diet May Help With Tough-to-Treat Epilepsy 2Health News:High-Fat, Low-Carb Diet May Help With Tough-to-Treat Epilepsy 3Health News:FDA Approves New Vaccine to Protect Against Meningitis 2Health News:Survival rates in pediatric umbilical cord transplants may indicate a new standard of care 2Health News:Survival rates in pediatric umbilical cord transplants may indicate a new standard of care 3Health News:Women who took part in VOICE speak up about why they didn't use HIV prevention products 2Health News:Women who took part in VOICE speak up about why they didn't use HIV prevention products 3
(Date:10/30/2014)... -- Zimmer Holdings, Inc. (NYSE: ZMH and ... and organizational structure of the combined company following the ... the combined organization will leverage the strength of both ... the new brand to be rolled out across the ... future leadership team is committed to establishing Zimmer Biomet ...
(Date:10/30/2014)... Oct. 30, 2014   ViaDerma, Inc. ... bringing new products to market, has recently released ... TetraStem is a topical liquid tetracycline-based antibiotic that ... can convert oral medication active ingredients into topical ... first aid antibiotic to help prevent skin infection ...
(Date:10/30/2014)... SAN FRANCISCO , Oct. 30, 2014  Nektar ... financial results for the third quarter ended September 30, ... of U.S.-based financial markets. Howard Robin , president ... to review the results beginning at 5:00 p.m. Eastern ... The press release and a live audio-only Webcast of ...
Breaking Medicine Technology:Zimmer Announces Executive Leadership Team and New Name of Combined Company Following Closing 2Zimmer Announces Executive Leadership Team and New Name of Combined Company Following Closing 3Zimmer Announces Executive Leadership Team and New Name of Combined Company Following Closing 4Zimmer Announces Executive Leadership Team and New Name of Combined Company Following Closing 5Zimmer Announces Executive Leadership Team and New Name of Combined Company Following Closing 6Zimmer Announces Executive Leadership Team and New Name of Combined Company Following Closing 7Zimmer Announces Executive Leadership Team and New Name of Combined Company Following Closing 8Zimmer Announces Executive Leadership Team and New Name of Combined Company Following Closing 9ViaDerma, Inc. Lead Product TetraStem Shown Effective in Fighting Staph Infections including MRSA 2ViaDerma, Inc. Lead Product TetraStem Shown Effective in Fighting Staph Infections including MRSA 3Nektar to Announce Financial Results for the Third Quarter 2014 on Thursday, November 6, 2014, After Close of U.S.-Based Financial Markets 2
Cached News: